Only ‘early’ estradiol limits atherosclerosis progression

Hormone therapy – estradiol with or without progesterone – only limits the progression of subclinical atherosclerosis if it is initiated within 6 years of menopause onset, according to a report...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news